Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2024-03-06 Regulatory Filings
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Group of companies' accounts made up to 2023-08-31
Regulatory Filings
2024-03-06 English
Investor Presentation via Investor Meet Company
Report Publication Announcement Classification · 99% confidence The document is an official announcement via RNS (RNS Number : 3035F) stating that the CEO and CFO will provide a live presentation relating to the FY2023 results via 'Investor Meet Company' on a future date (07 Mar 2024). This announcement is about scheduling an investor presentation, not the presentation document itself, nor is it the full earnings release (ER) or the comprehensive interim report (IR). The core subject is the upcoming investor presentation event. This aligns best with the Investor Presentation (IP) category, as it is an announcement promoting an upcoming presentation where financial results will be discussed in detail, which is distinct from the initial 'ER' release.
2024-03-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Spreadex LTD regarding Oncimmune Holdings PLC. This form reports a change in the percentage of voting rights held by an entity, specifically crossing or reaching a notification threshold (Section 5 and 7). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-02-29 English
Final Results
Regulatory Filings Classification · 98% confidence The document is an RNS announcement dated February 29, 2024. It explicitly states that it announces the 'audited results for the 12-month period ended 31 August 2023 ("FY 2023")' and provides key financial highlights for FY 2023 and an outlook for FY 2024. It also mentions that the full 'Annual Report and Financial Statements 2023' will be available later today. Because this document is an announcement summarizing results and outlook, and not the full, comprehensive annual report itself (which is mentioned as forthcoming separately), it fits best as an Earnings Release (ER) or potentially a Regulatory Filing (RNS). Given that it contains detailed financial highlights, management commentary, and operational reviews for a full fiscal year, it is more substantial than a typical quarterly Earnings Release (ER). However, it is not the full 10-K. Since it is a formal announcement of annual results via RNS, and the full Annual Report (10-K equivalent) is stated to be published separately, the most accurate classification for this type of preliminary results announcement is often the general Regulatory Filing (RNS) or, if the content strongly resembles a full report summary, an Annual Report (AR) if it's not the 10-K. Since the document explicitly states it is announcing the audited results and provides extensive detail, but also notes the full Annual Report is coming later, it functions as a comprehensive summary of the year's performance. Given the options, and the fact that it is a formal regulatory announcement (RNS Number: 8514E) detailing the results of the fiscal year, RNS is a safe classification, but since it details the audited results, AR (Audit Report/Information) is also plausible if it's the primary release of the audited figures before the full 10-K filing. However, the presence of the RNS header and the statement that the full Annual Report is coming later strongly suggests this is the initial regulatory disclosure of the annual results, which aligns well with the general 'Regulatory Filings' (RNS) category for official announcements, or potentially an Earnings Release (ER) if we interpret 'audited results' announcement as the primary earnings disclosure. Given the comprehensive nature covering the full year and management review, and the explicit RNS header, RNS is the most appropriate catch-all for this type of regulatory disclosure that precedes the formal 10-K/Annual Report filing.
2024-02-29 English
Result of AGM
AGM Information Classification · 99% confidence The document is an RNS announcement dated February 26, 2024, titled "Results of Annual General Meeting". It explicitly states that all resolutions at the AGM held earlier today were duly passed. This content directly relates to the outcomes of a shareholder meeting. According to the definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) covers official results from shareholder votes at any general meeting. Although it mentions future actions (receiving the annual report at a later general meeting), the primary subject of this specific release is the results of the AGM that just concluded. Therefore, DVA is the most appropriate classification.
2024-02-26 English
Notice of AGM
AGM Information Classification · 98% confidence The document is titled 'Notice of Annual General Meeting' and explicitly states that the AGM will be held on February 26, 2024. It also mentions that the 'Notice of AGM has been sent to shareholders'. This directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the upcoming Annual Report (10-K), the primary purpose and subject of this specific filing is the notice for the Annual General Meeting.
2024-02-02 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.